CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250114331A1
SERIAL NO

18293456

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subject to chemotherapy and/or immunotherapy comprising the step of administering to the subject an effective amount of a YAP1 inhibitor and a STAT3 inhibitor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIV JOHNS HOPKINS3400 NORTH CHARLES STREET BALTIMORE MARYLAND 21218 US

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoque, Mohammad O Towson, US 7 2
Sadhukhan, Pritam Baltimore, US 2 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation